Pharmabiz7h
Memo Therapeutics appoints Frits van Alphen, MD as chief development officer
Memo Therapeutics AG (MTx), a late-stage biotech company translating unique immune responses into superior medicines to treat ...
Pharmabiz12h
Novo Nordisk announces positive results from phase 3 ESSENCE trial of semaglutide 2.4 mg to treat adults with MASH and liver fibrosis
Novo Nordisk, a leading global healthcare company, announced the headline results from part 1 of the ongoing ESSENCE trial, a pivotal phase 3, 240-week, double-blinded trial in 1,200 adults with ...
Pharmabiz8m
HuidaGene Therapeutics gets US FDA clearance for CRISPR/Cas13 RNA-editing HG202 for macular degeneration
HuidaGene Therapeutics (HuidaGene), a global clinical-stage biotechnology company developing genome medicines, announced that the US FDA has cleared its HG202 investigational new drug (IND) ...
Pharmabiz16h
STADA opens new production site & supply-chain hub in Turda, Romania with an investment of US$ 75 million
STADA opens new production site & supply-chain hub in Turda, Romania with an investment of US$ 75 million: Bad Vilbel, ...
Pharmabiz12h
Gland Pharma in Q2FY25 reports Rs. 1,405.8 crore revenue and profit dip by 16% at Rs.163.5 crore
Gland Pharma in Q2FY25 reports Rs. 1,405.8 crore revenue and profit dip by 16% at Rs.163.5 crore: Our Bureau, Bengaluru Tuesday, November 5, 2024, 16:15 Hrs [IST] Gland Pharma, a ...
Pharmabiz11h
Healthcare payments company QubeHealth raises pre series A from Unicorn India Ventures and CanBank VC
Healthcare payments company QubeHealth raises pre series A from Unicorn India Ventures and CanBank VC: Our Bureau, Bengaluru Tuesday, November 5, 2024, 16:30 Hrs [IST] Deep-tech f ...
Pharmabiz16h
Venus Remedies’ Baddi robotic pre-filled syringe facility receives Malaysian PIC/S GMP approval
Venus Remedies’ Baddi robotic pre-filled syringe facility receives Malaysian PIC/S GMP approval: Our Bureau, Mumbai Tuesday, November 5, 2024, 12:15 Hrs [IST] Venus Remedies Lim ...
Pharmabiz13h
Prokarium expands IP portfolio with two new US patents strengthening its position in bladder cancer
Prokarium expands IP portfolio with two new US patents strengthening its position in bladder cancer: London, UK Tuesday, November 5, 2024, 15:00 Hrs [IST] Prokarium, a biopharmace ...
Pharmabiz15h
PURE Bioscience enters multi-year distribution agreement with Quip Labs
PURE Bioscience enters multi-year distribution agreement with Quip Labs: El Cajon, California Tuesday, November 5, 2024, 13:00 Hrs [IST] PURE Bioscience, Inc., creator of the pate ...
Pharmabiz17h
Arun Swaminathan assumes new role as chief executive officer of Coya Therapeutics
Arun Swaminathan assumes new role as chief executive officer of Coya Therapeutics: Houston Tuesday, November 5, 2024, 11:00 ...
Pharmabiz6h
MannKind completes phase 1 trial of nintedanib DPI for pulmonary fibrotic diseases
MannKind Corporation, a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced ...
Pharmabiz10h
Diadem presents new findings on early Alzheimer’s disease detection using p53-specific antibody at CTAD 2024
Diadem presents new findings on early Alzheimer’s disease detection using p53-specific antibody at CTAD 2024: Milano, Italy Tuesday, November 5, 2024, 18:00 Hrs [IST] Diadem SpA ...